|
|
Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clinical pharmacology and therapeutics. 2011. Sadee W, et al. [Article:21289622@PubMed] |
|
|
Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives. European journal of clinical pharmacology. 2011. Russo Roberta, et al. [Article:21069522@PubMed] |
|
|
Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs. Genes, brain, and behavior. 2011. Falcone Mary, et al. [Article:21883922@PubMed] |
|
|
Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics. 2011. Mukherjea Debashree, et al. [Article:21787192@PubMed] |
|
|
Tolcapone, COMT polymorphisms and pharmacogenomic treatment of schizophrenia. Pharmacogenomics. 2011. Bitsios Panos, et al. [Article:21521027@PubMed] |
|
|
Analysis of 94 Candidate Genes and 12 Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia. The American journal of psychiatry. 2011. Greenwood Tiffany A, et al. [Article:21498463@PubMed] |
|
|
Economic impact of a genetic test for cisplatin-induced ototoxicity. The pharmacogenomics journal. 2011. Dionne F, et al. [Article:21502965@PubMed] |
|
|
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. Transplantation. 2011. Jacobson Pamala A, et al. [Article:21206424@PubMed] |
|
|
Reduced 3-O-methyl-dopa levels in OCD patients and their unaffected parents is associated with the low activity M158 COMT allele. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2010. Delorme Richard, et al. [Article:19676096@PubMed] |
|
|
Breaking Barriers in the Genomics and Pharmacogenetics of Drug Addiction. Clinical pharmacology and therapeutics. 2010. Ho M K, et al. [Article:20981002@PubMed] |
|
|
Pharmacogenetics of antidepressive treatment. European archives of psychiatry and clinical neuroscience. 2010. Zobel Astrid, et al. [Article:20047055@PubMed] |
|
|
Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study. Pharmacogenetics and genomics. 2010. Tchivileva Inna E, et al. [Article:20216107@PubMed] |
|
|
Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17alpha in preeclampsia. Pharmacogenetics and genomics. 2010. Lim Ji Hyae, et al. [Article:20729792@PubMed] |
|
|
A current update on ADHD pharmacogenomics. Pharmacogenomics. 2010. Kieling Christian, et al. [Article:20235795@PubMed] |
|
|
Pharmacogenetics of lithium response in bipolar disorder. Pharmacogenomics. 2010. McCarthy Michael J, et al. [Article:21047205@PubMed] |
|
|
Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response. The pharmacogenomics journal. 2010. Ji Y, et al. [Article:20877297@PubMed] |
|
|
Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder. Biological psychiatry. 2009. Perlis Roy H, et al. [Article:19095219@PubMed] |
|
|
Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. Clinical pharmacology and therapeutics. 2009. Bodenmann S, et al. [Article:19037200@PubMed] |
|
|
The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain. Clinical pharmacology and therapeutics. 2009. Lötsch J, et al. [Article:18548001@PubMed] |
|
|
MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2009. Hilli Johanna, et al. [Article:19223155@PubMed] |
|
|
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nature genetics. 2009. Ross Colin J D, et al. [Article:19898482@PubMed] |
|
|
Catechol O-methyltransferase pharmacogenomics: human liver genotype-phenotype correlation and proximal promoter studies. Pharmacogenetics and genomics. 2009. Zhang Jianping, et al. [Article:19641441@PubMed] |
|
|
Variants in COMT and spontaneous smoking cessation: retrospective cohort analysis of 925 cessation events. Pharmacogenetics and genomics. 2009. Breitling Lutz Philipp, et al. [Article:19584770@PubMed] |
|
|
Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Pharmacogenomics. 2009. Gupta Meenal, et al. [Article:19290789@PubMed] |
|
|
Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics. 2009. Gupta Meenal, et al. [Article:19207030@PubMed] |
|
|
Variation in the COMT gene: implications for pain perception and pain treatment. Pharmacogenomics. 2009. Andersen Sonja, et al. [Article:19374521@PubMed] |
|
|
A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. The pharmacogenomics journal. 2009. Gassó P, et al. [Article:19506579@PubMed] |
|
|
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia. The pharmacogenomics journal. 2009. Fijal B A, et al. [Article:19451915@PubMed] |
|
|
Pharmacogenetics of morphine: Potential implications in sickle cell disease. American journal of hematology. 2008. Darbari Deepika S, et al. [Article:17722074@PubMed] |
|
|
Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. American journal of human genetics. 2008. Mill Jonathan, et al. [Article:18319075@PubMed] |
|
|
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions. Molecular psychiatry. 2008. Bakker P R, et al. [Article:18180754@PubMed] |
|
|
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nature genetics. 2008. Allen Nicole C, et al. [Article:18583979@PubMed] |
|
|
Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2008. Lohoff Falk W, et al. [Article:18704099@PubMed] |
|
|
COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2008. Sengupta Sarojini, et al. [Article:18580877@PubMed] |
|
|
Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2008. Giakoumaki Stella G, et al. [Article:18536698@PubMed] |
|
|
Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenetics and genomics. 2008. Munafò Marcus R, et al. [Article:18192898@PubMed] |
|
|
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Pharmacogenetics and genomics. 2008. Bialecka Monika, et al. [Article:18698234@PubMed] |
|
|
Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. Pharmacogenomics. 2008. Madadi Parvaz, et al. [Article:18781855@PubMed] |
|
|
Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biological psychiatry. 2007. Berrettini Wade H, et al. [Article:16876132@PubMed] |
|
|
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007. Johnstone Elaine C, et al. [Article:17548664@PubMed] |
|
|
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain. 2007. Reyes-Gibby Cielito C, et al. [Article:17156920@PubMed] |
|
|
Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 2007. Mandelli Laura, et al. [Article:16756688@PubMed] |
|
|
Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. The pharmacogenomics journal. 2007. Molero P, et al. [Article:17363961@PubMed] |
|
|
Estrogens, enzyme variants, and breast cancer: a risk model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006. Crooke Philip S, et al. [Article:16985022@PubMed] |
|
|
Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase. Cellular and molecular neurobiology. 2006. Weinshilboum Richard M. [Article:16807786@PubMed] |
|
|
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics. Journal of clinical psychopharmacology. 2006. Nolan Karen A, et al. [Article:16702905@PubMed] |
|
|
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Journal of the National Cancer Institute. 2006. Rebbeck Timothy R, et al. [Article:16985250@PubMed] |
|
|
Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science (New York, N.Y.). 2006. Nackley A G, et al. [Article:17185601@PubMed] |
|
|
Estrogen carcinogenesis in breast cancer. The New England journal of medicine. 2006. Yager James D, et al. [Article:16421368@PubMed] |
|
|
Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Human genetics. 2005. Lee Seong-Gene, et al. [Article:15645182@PubMed] |
|
|
Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. International journal of cancer. Journal international du cancer. 2005. Cheng Ting-Chih, et al. [Article:15455371@PubMed] |
|
|
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors. Neuropsychiatric disease and treatment. 2005. Lotrich Francis E, et al. [Article:18568127@PubMed] |
|
|
COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2005. Stein Murray B, et al. [Article:15956988@PubMed] |
|
|
Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer. Oncology reports. 2005. Inoue Hiroshi, et al. [Article:16077979@PubMed] |
|
|
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain. 2005. Rakvåg Trude Teoline, et al. [Article:15927391@PubMed] |
|
|
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenetics and genomics. 2005. Colilla Susan, et al. [Article:15900212@PubMed] |
|
|
Pharmacogenetics of antihypertensive drug responses. American journal of pharmacogenomics : genomics-related research in drug development and clinical practice. 2004. Schwartz Gary L, et al. [Article:15174896@PubMed] |
|
|
Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biological psychiatry. 2004. Weickert Thomas W, et al. [Article:15522252@PubMed] |
|
|
COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Molecular psychiatry. 2004. Palmatier M A, et al. [Article:15098000@PubMed] |
|
|
Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Molecular psychiatry. 2004. Shield A J, et al. [Article:14966473@PubMed] |
|
|
Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Molecular psychiatry. 2004. Chen X, et al. [Article:15124004@PubMed] |
|
|
The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2004. Bilder Robert M, et al. [Article:15305167@PubMed] |
|
|
Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics. Pharmacogenetics. 2004. Anttila Sami, et al. [Article:15115916@PubMed] |
|
|
Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. The American journal of psychiatry. 2004. Bertolino Alessandro, et al. [Article:15465976@PubMed] |
|
|
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Therapeutic drug monitoring. 2004. de la Torre Rafael, et al. [Article:15228154@PubMed] |
|
|
Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2003. Inada Toshiya, et al. [Article:12815736@PubMed] |
|
|
The role of genetic factors in the development of hyperhomocysteinemia. Clinical chemistry and laboratory medicine : CCLM / FESCC. 2003. Geisel Jürgen, et al. [Article:14656021@PubMed] |
|
|
Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2003. Illi Ari, et al. [Article:12729939@PubMed] |
|
|
Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk. International journal of cancer. Journal international du cancer. 2003. Saintot Monique, et al. [Article:14520706@PubMed] |
|
|
Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia. Journal of clinical psychopharmacology. 2003. Illi Ari, et al. [Article:14520117@PubMed] |
|
|
L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patients. Journal of neural transmission (Vienna, Austria : 1996). 2003. Dousa M K, et al. [Article:12898345@PubMed] |
|
|
Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatric genetics. 2003. Enoch Mary-Anne, et al. [Article:12605099@PubMed] |
|
|
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (New York, N.Y.). 2003. Zubieta Jon-Kar, et al. [Article:12595695@PubMed] |
|
|
Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. The pharmacogenomics journal. 2003. Yamanouchi Y, et al. [Article:14610521@PubMed] |
|
|
A highly significant association between a COMT haplotype and schizophrenia. American journal of human genetics. 2002. Shifman Sagiv, et al. [Article:12402217@PubMed] |
|
|
Association between the COMT locus and obsessive-compulsive disorder in females but not males. American journal of medical genetics. 2002. Alsobrook John P, et al. [Article:11840516@PubMed] |
|
|
Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Archives of toxicology. 2002. Kocaba¿ Neslihan Aygün, et al. [Article:12415427@PubMed] |
|
|
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological psychiatry. 2002. Bilder Robert M, et al. [Article:12372660@PubMed] |
|
|
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer cell. 2002. Yeoh Eng-Juh, et al. [Article:12086872@PubMed] |
|
|
Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2002. Goudreau John L, et al. [Article:12465073@PubMed] |
|
|
Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics. 2002. Mitrunen Katja, et al. [Article:11773866@PubMed] |
|
|
Catechol O-methyltransferase genetic polymorphism in panic disorder. The American journal of psychiatry. 2002. Woo Jong-Min, et al. [Article:12359690@PubMed] |
|
|
Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. The pharmacogenomics journal. 2002. Dauvilliers Y, et al. [Article:11990384@PubMed] |
|
|
Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2001. Mitrunen K, et al. [Article:11401913@PubMed] |
|
|
Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. International journal of clinical oncology / Japan Society of Clinical Oncology. 2001. Hamajima N, et al. [Article:11706521@PubMed] |
|
|
Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan. Neuropsychobiology. 2001. Liou Y J, et al. [Article:11150892@PubMed] |
|
|
Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics. 2001. Yim D S, et al. [Article:11434504@PubMed] |
|
|
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2001. Egan M F, et al. [Article:11381111@PubMed] |
|
|
Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatric genetics. 2001. Herken H, et al. [Article:11525417@PubMed] |
|
|
Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. American journal of medical genetics. 2000. Horowitz R, et al. [Article:11054766@PubMed] |
|
|
Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biological psychiatry. 1999. Palmatier M A, et al. [Article:10459407@PubMed] |
|
|
Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer research. 1999. Huang C S, et al. [Article:10519398@PubMed] |
|
|
Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer research. 1998. Thompson P A, et al. [Article:9605753@PubMed] |
|
|
Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression. Neuroreport. 1998. Ohara K, et al. [Article:9631418@PubMed] |
|
|
Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neuroscience letters. 1998. Ohmori O, et al. [Article:9535125@PubMed] |
|
|
High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. American journal of medical genetics. 1997. Vandenbergh D J, et al. [Article:9259381@PubMed] |
|
|
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer research. 1997. Lavigne J A, et al. [Article:9407957@PubMed] |
|
|
Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics. 1997. Li T, et al. [Article:9352569@PubMed] |
|
|
Molecular mechanisms of estrogen carcinogenesis. Annual review of pharmacology and toxicology. 1996. Yager J D, et al. [Article:8725388@PubMed] |
|
|
Catechol-O-methyltransferase activity: a determinant of levodopa response. Clinical pharmacology and therapeutics. 1980. Reilly D K, et al. [Article:7398195@PubMed] |